Protective Effect of N-acetylcysteine Against From Ototoxicity
NCT01271088
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Hearing Loss, Extreme
Interventions
DRUG:
N-acetylcysteine
Sponsor
TC Erciyes University